Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2016: 3.273

CiteScore 2016: 3.01

SCImago Journal Rank (SJR) 2016: 1.679
Source Normalized Impact per Paper (SNIP) 2016: 0.800

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 396, Issue 5 (May 2015)

Issues

Redox regulation of T-cell receptor signaling

Luca Simeoni
  • Corresponding author
  • Institute of Molecular and Clinical Immunology, Otto von Guericke University, Leipziger Straße 44, D-39120 Magdeburg, Germany
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ivan Bogeski
Published Online: 2015-03-10 | DOI: https://doi.org/10.1515/hsz-2014-0312

Abstract

T-cell receptor (TCR) triggering by antigens activates a sophisticated intracellular signaling network leading to transcriptional activation, proliferation and differentiation of T cells. These events ultimately culminate in adaptive immune responses. Over recent years it has become evident that reactive oxygen species (ROS) play an important role in T-cell activation. It is now clear that ROS are involved in the regulation of T-cell mediated physiological and pathological processes. Upon TCR triggering, T cells produce oxidants, which originate from different cellular sources. In addition, within inflamed tissues, T cells are exposed to exocrine ROS produced by activated phagocytes or other ROS-producing cells. Oxidative modifications can have different effects on T-cell function. Indeed, they can stimulate T-cell activation but they can be also detrimental. These opposite effects of oxidation likely depend on different factors such as ROS concentration and source and also on the differentiation status of the T cells. Despite the well-stablished fact that ROS represent important modulators of T-cell activation, the precise molecular mechanisms of their action are far from clear. Here, we summarize the present knowledge on redox regulation of T-cell function with a particular emphasis on the redox regulation of TCR signaling.

Keywords: calcium; mitochondria; NADPH oxidase; redox; ROS; T-cell; T-cell activation; TCR signaling; thiol switch

Introduction

The immune system is equipped with a variety of anti-microbial factors including complement proteins, antibodies and small chemically active molecules (e.g., reactive oxygen species, ROS) to fight against invading pathogens. During the last years, it has become clear that, in addition to their microbicidal activity, these substances possess important immunoregulatory functions that are required to guarantee a correct spatial and temporal proceeding of the immune response. In particular, ROS have recently emerged as important modulators of activation, proliferation, and apoptosis in many cell types (Valko et al., 2007).

Among all ROS, superoxide anion radical (O2·-) and hydrogen peroxide (H2O2) are probably the biologically most important ones (Droge, 2002). Within this review, we use the abbreviation ROS for simplicity. However, in most cases ROS in T cells are mainly represented by O2·- and H2O2. They can be generated by both enzymatic and non-enzymatic systems, including mitochondria and NOX complexes, in the intracellular as well as in the extracellular space (Bedard and Krause, 2007; Bogeski et al., 2011; Sies, 2014; Zorov et al., 2014). O2·- is generated upon transfer of electrons to the free molecular oxygen. O2·- is highly unstable and is rapidly transformed into H2O2 either spontaneously or by superoxide dismutase (SOD). H2O2 can react with the thiol of cysteine residues resulting in the formation of sulfenic acid (Kettenhofen and Wood, 2010). This posttranslational modification – known as sulfenylation – is reversible (e.g., by GSH) and can modulate the function of the targeted protein. Additional reversible cysteine modifications include glutathionylation, S-nitrosylation, S-acylation, sulfenylamide formation, and the generation of disulfide bridges. Therefore, cysteine residues have recently become the focus of intensive investigation, as they function as ‘switches’ upon oxidation/reduction of thiol groups. The emerging idea is that reversible oxidation of cysteines is akin to phosphorylation of tyrosine, threonine, and serine residues and represents a novel global regulatory mechanism during signal transduction.

In this review, we discuss the role of ROS as modulators of T-cell activation with a particular emphasis on oxidative modification on cysteine of molecules involved in TCR signaling. A number of studies have shown that imbalance in redox homeostasis characterizes many immune-related diseases (Staal et al., 1992; Chrobot et al., 2000; Kovacic and Jacintho, 2001; Reyes et al., 2005; Hultqvist et al., 2009; Kesarwani et al., 2013; Padgett et al., 2013). Nevertheless, despite intensive investigations during the last decade, mechanistic insights of how oxidation regulates T-cell signaling have not yet been completely revealed.

T-cell activation

T cells are organized in highly specialized subsets (e.g., CD4+ helper, CD8+ cytotoxic, and CD4+CD25+ regulatory T cells) coordinating both humoral and cellular immune responses. They express a specific receptor for antigens on their cell surface called T-cell receptor (TCR). Antigens are presented in complex with MHC molecules on antigen presenting cells (APCs) such as dendritic cells, macrophages, and B cells. Upon recognition of the antigens by the TCR, a signal is triggered within T cells, thus leading to transcriptional activation, proliferation, differentiation, and immune responses. Alterations in TCR-mediated signaling are at the basis of many human diseases such as autoimmunity, immunodeficiency, and cancer. Therefore, in recent years efforts were made to investigate how the TCR-mediated signaling network is regulated.

In this section we summarize how TCR signaling is regulated. For more details on T-cell activation we recommend the following excellent reviews: Acuto et al. (2008); Chakraborty and Weiss (2014); Samelson (2011); Smith-Garvin et al. (2009).

Initiation of TCR signaling: the critical role of Lck and Zap-70

The TCR is a multi-protein complex including an αβTCR heterodimer (or γδTCR in a minor subset of T cells), which recognizes antigens, and the signal transducing units CD3γε, CD3δε, and TCRζζ. In their cytoplasmic domains, CD3 and TCRζ chains possess a particular amino acid sequence, called immunoreceptor tyrosine-based activation motifs (ITAMs), containing two core tyrosines that are required for signaling (Figure 1).

Schematic representation of TCR-mediated signaling. TCR ligation by antigens induces Lck activation, ITAM phosphorylation, and the recruitment and activation of Zap-70. Zap-70 in turn phosphorylates LAT, thus leading to the formation of the LAT signalosome. This complex triggers additional signaling cascades leading to NFAT, AP1, and NFkB activation, thus resulting in IL-2 production and T-cell activation.
Figure 1:

Schematic representation of TCR-mediated signaling.

TCR ligation by antigens induces Lck activation, ITAM phosphorylation, and the recruitment and activation of Zap-70. Zap-70 in turn phosphorylates LAT, thus leading to the formation of the LAT signalosome. This complex triggers additional signaling cascades leading to NFAT, AP1, and NFkB activation, thus resulting in IL-2 production and T-cell activation.

Upon recognition of the antigen, tyrosines within ITAMs are phosphorylated by members of the Src-family tyrosine kinases such as Lck (lymphocyte-specific protein tyrosine kinase). Activation of Lck is regulated upon the phosphorylation of two conserved tyrosine residues, Y394 and Y505. Auto-trans-phosphorylation of Y394, located in the kinase domain, activates Lck, whereas the phosphorylation of the inhibitory Y505, located in the C-terminus, by the non-receptor tyrosine kinase Csk inhibits Lck’s enzymatic activity. A number of tyrosine phosphatases have been reported to dephosphorylate the regulatory sites within Lck. There is evidence that CD45 play a major role as positive regulator of Lck activity upon dephosphorylation of the inhibitory Y505, which will in turn result in Lck activation (for a review on the role of phosphatases in the regulation of TCR signaling see Mustelin et al., 2005). Other phosphatases such as Shp1 and LYP/PEP have been shown to be important inhibitors of Lck activity by dephosphorylating Y394. The reason why much attention has been given to the analysis of the regulation of Lck activity is that, among the Src-family kinases, Lck appears to be the most important in T cells. In fact, Lck-/- mice show a severe block in T-cell development (Molina et al., 1992) and Lck-deficient Jurkat T cells display impaired proximal TCR signaling (Goldsmith and Weiss, 1987).

Active Lck in turn phosphorylates the ITAMs (Figure 1). Phosphorylation of the ITAMs allows the recruitment of ZAP-70, a protein tyrosine kinase with two tandem SH2 domains, to the activated receptor (Wang et al., 2010). Binding to the ITAMs results in the perturbation of the auto-inhibited conformation of Zap-70. Phosphorylation of the activatory Y493 by Lck or Zap-70 itself results in full activation. The additional phosphorylation of Y315 and Y319 within Zap-70 further stabilizes the active enzyme and additionally serves as docking sites for other effector molecules including Vav and Lck. Similarly to Lck, Zap-70 is also dephosphorylated and inactivated by phosphatases such as Shp1 and LYP/PEP (Mustelin et al., 2005). Zap-70 is required during thymic development, which is completely blocked in Zap-70-deficient mice (Negishi et al., 1995). Additionally, Zap-70 is required for signaling downstream of the TCR in mature T cells. Indeed, a Zap-70-deficient Jurkat T-cell variant (P116) displays impaired TCR-mediated signaling (Williams et al., 1998).

Diversification of the signal: the LAT signalosome

Activated ZAP-70 in turn phosphorylates the two adaptor proteins LAT and SLP-76, which form the backbone of a signaling complex required for the diversification of the signal, thus leading to transcriptional activation, cytoskeleton reorganization, proliferation and differentiation of T cells (Figure 1) (Wange, 2000). A crucial event triggered by the LAT signalosome is the activation of PLCγ-1, which cleaves PIP2 thus generating the second messengers DAG and IP3. DAG activates PKCs, which in turn orchestrate the activation of the CBM complex including Bcl10, MALT1 and CARMA1 leading to NF-κB activation (Lin and Wang, 2004). Conversely, DAG is also crucial for the initiation of Ras-Erk signaling, which is indispensable for the activation of the transcription factor AP1 (Roose and Weiss, 2000). Ras activation is triggered upon recruitment of RasGRP1 to the plasma membrane via DAG. RasGRP1 will in turn enhance the generation of active Ras leading to the activation of the Raf-Mek-Erk cascade. However, for sustained Ras signaling and T-cell activation the activity of Sos1 is also required (Roose et al., 2007; Das et al., 2009; Warnecke et al., 2012; Poltorak et al., 2014).

IP3, however, activates the IP3 receptors (IP3R) at the endoplasmic reticulum (ER) membrane and causes depletion of the intracellular ER Ca2+ stores, thereby triggering accumulation of the ER Ca2+ sensor proteins STIM1 and STIM2 (Figure 1) (Liou et al., 2005; Zhang et al., 2005). Clustered STIM proteins directly couple and activate Ca2+-influx through Ca2+ release-activated Ca2+ (CRAC) channels in a process known as store-operated Ca2+ entry (SOCE) (Hoth and Penner, 1992; Parekh and Putney, 2005). In T cells CRAC channels are mainly formed by Orai1 (Feske et al., 2006) although heteromeric channels can assemble with both Orai2 and Orai3 (Lis et al., 2007; Schindl et al., 2009). Humans with mutations in Orai1 or STIM1 have severely impaired SOCE and consequently defective T-cell proliferation and cytokine production (Feske, 2009). Ca2+ signaling will lead to the activation of the transcription factor NFAT.

In summary, the signal triggered at the plasma membrane will culminate in the activation of NFkB, AP-1, and NFAT, which will in turn regulate IL-2 transcription in the nucleus. IL-2 production will further support T-cell proliferation and immune responses.

T-cell activation is sensitive to oxidation

In the 1980s, different groups demonstrated that oxidation is crucial for T-cell proliferation. Initial data, generated using compounds known to scavenge free radicals, demonstrated that PMA-induced proliferation of human peripheral lymphocytes was inhibited upon scavenging of hydroxyl radicals (Novogrodsky et al., 1982). Similarly, Ceredig and colleagues showed that several antioxidant compounds inhibit the proliferation of T cells stimulated with both alloantigen and PMA and ionomycin (Chaudhri et al., 1986, 1988). Additional data suggested that antioxidants affect T-cell proliferation by inhibiting IL-2 expression (Gerber et al., 1985; Chaudhri et al., 1988; Fidelus, 1988; Sekkat et al., 1988; Dornand and Gerber, 1989; Roth and Droge, 1991; Tatla et al., 1999). Collectively, these initial observations indicated that oxygen radicals are involved in the regulation of T-cell activation. Nevertheless, additional studies have complicated this simple view. Indeed, it has been shown that H2O2 may inhibit and, under particular conditions, also stimulate lymphocyte proliferation (Roth and Droge, 1987; Patterson et al., 1988; Los et al., 1995a). Also, studies from Tsan and colleagues showed that increasing amount of intracellular antioxidants such as glutathione (GSH) increased the proliferation of murine splenic lymphocytes in response to mitogens (Fidelus and Tsan, 1986, 1987; Fidelus et al., 1987). The importance of the intracellular GSH pool in T-cell activation has been also shown using inhibitors of GSH synthesis, which reduced CD3-mediated proliferation and IL-2 production (Gmunder et al., 1990; Suthanthiran et al., 1990; Smyth, 1991; Hehner et al., 2000). More recently, it has been shown that natural antioxidants such as SOD, catalase, and ascorbate do not have any effects on the proliferation of human primary T cells upon CD3×CD28 stimulation (Belikov et al., 2014). Thus, after three decades of intense scrutiny, it is still controversial whether ROS support or suppress T-cell functions. The observed discrepancies may be the result of different T-cell subsets used in these studies such as T-cell lines, T-cell blasts, human peripheral blood T cells, murine splenocytes and thymocytes, CD4+, CD8+, memory or naïve T cells, which may have a different intracellular redox equilibrium and hence have different sensitivities to oxidation. Indeed, it has been observed that T cells isolated from the intestinal lamina propria express significantly higher levels of GSH compared to peripheral blood T cells and hence display a different sensitivity to H2O2 (Reyes et al., 2005). Additionally, the different stimulation conditions used in these studies, including PMA and ionophores, lectins such as ConA and PHA, agonistic antibodies such as CD3 alone or in combination with the costimulatory molecule CD28, IL-2, alloreactions, may also activate different signaling pathways that may be more or less sensitive to oxidation. Finally, also the different concentrations (in some cases ranging above physiological levels) and chemical properties of antioxidants or inhibitors used in the studies, which may have off-targets effects, could help to explain the conflicting results.

The Ws of ROS production in T cells: when, where, what, and why

The observation that antioxidants and H2O2 affected T-cell activation raised the question whether, similarly to other immune cells such as phagocytes, T cells also produce ROS. Studies from different groups have indeed shown that TCR triggering results in the generation of both O2·- and H2O2 in human and mouse T-cell blasts, primary T cells, and also in Jurkat T cells (Devadas et al., 2002; Kwon et al., 2003, 2010; Jackson et al., 2004; Remans et al., 2004; Jones et al., 2007; Gutscher et al., 2008; Kaminski et al., 2012; Sena et al., 2013; Belikov et al., 2014). The specificity of ROS production in T cells has long been a debated issue, for a review see Williams and Kwon (2004). One of the main problems in this regard is that, in comparison with professional phagocytes, T cells generate much lower amounts of ROS upon TCR ligation. This makes the measurement of specific TCR-mediated ROS a difficult task. For example, extracellular O2·- production by anti-CD3/CD28 bead activated T cells could not be measured using electron paramagnetic resonance (EPR) but could be detected by the H2O2-sensitive genetically encoded protein sensor HyPer [Bogeski et al. unpublished data (Mishina et al., 2012)]. Additional problems may be encountered when measuring specific TCR-mediated ROS production. Indeed, under culture conditions cell stress may induce alterations of the redox status and lead to unspecific detection of ROS in the absence of TCR stimulation. Additionally, in non-single cell studies the generation of ROS from contaminating phagocytes present in T-cell preparations isolated from lymphoid tissues may lead to artifacts. In fact, we have found a significant release of O2·- upon stimulation of T-cell suspensions (whose purity more than 96%) with isotype controls (Belikov et al., 2014). It is believed that this non-TCR-mediated O2·- originates upon stimulation of Fc receptors on monocytes contaminating purified T-cell suspensions (Williams and Kwon, 2004; Belikov et al., 2014).

The recent development of new tools such as genetically encoded biosensors, which detect intracellular H2O2 production or GSH/GSSG ratio, certainly represents an important advance in the analysis of specific ROS production in T cells (Gutscher et al., 2008; Mishina et al., 2012). Using these methods, it has been demonstrated that TCR engagement leads to a discrete generation of intracellular ROS and to a shift in the GSH/GSSG ratio.

When and where are ROS generated?

The data suggest that T cells produce O2·- and H2O2 rapidly (within few minutes) upon TCR stimulation (Devadas et al., 2002; Mishina et al., 2012; Belikov et al., 2014). ROS production can be sustained and last up to 60 min upon stimulation (Belikov et al., 2014). Interestingly, kinetics of ROS production appears to correlate with phosphorylation kinetics induced by TCR ligation (Arndt et al., 2013). These observations reinforce the idea that O2·- and H2O2 may play a role in the regulation of signaling events during T-cell activation.

The rapid induction of ROS upon TCR stimulation appears to depend on NADPH oxidases (NOX) (Jackson et al., 2004; Belikov et al., 2014). The NOX family of enzymes consists of seven members (NOX 1–5 and two dual oxidases, DUOX 1 and 2). Many cells express some or more subtypes of NOX. In T cells NOX2 and DUOX1 are, most likely, the predominant NOX isoforms (Jackson et al., 2004; Kwon et al., 2010). Once activated these enzymes assemble at the plasma membrane and generate O2·- by transferring electrons from the cytosolic NADPH to the free molecular oxygen. Subsequently, the highly unstable O2·- is rapidly transformed into H2O2 (Bedard and Krause, 2007). NOX2 is an important source of ROS in T cells as NOX2-deficient T cells display strongly reduced O2·- and H2O2 production (Jackson et al., 2004; Belikov et al., 2014). However, whether NOX2-derived ROS are required for T-cell activation is still debated. In fact, NOX2-deficient T cells display normal T-cell activation and proliferation (Belikov et al., 2014).

Also DUOX1 has been implicated in H2O2 production in T cells. Suppression of DUOX1 expression by siRNAs strongly decreased anti-CD3-mediated oxidation of H2-DCFDA (Kwon et al., 2010). It is believed that DUOX1 mediates a positive feed-back loop that promotes proximal TCR signaling by inactivating Shp-2 in Jurkat T cells and CD4+ T-cell blasts.

Also mitochondria produce O2·- and H2O2, which appear to play an important function in T cells [for the interested reader we recommend a recently published review on the role of mitochondrial oxidative signaling in T-cell activation, Kaminski et al. (2013)]. The functional role of these organelles and their oxidant production in T cells was reported some decades ago. These initial reports suggested that mitochondria, via their O2·- and H2O2, induce at least two apoptotic pathways thereby controlling apoptosis of activated T cells. Several excellent reviews, which we highly recommend to the interested reader, describe the role of redox signaling in T-cell apoptosis (Hildeman et al., 1999, 2003; Akhand et al., 2002; Ueda et al., 2002; Tripathi and Hildeman, 2004; Sena and Chandel, 2012).

How do mitochondria produce ROS? TCR ligation is followed by a rapid increase in cytosolic Ca2+. A minor fraction of this Ca2+ is released by the ER, while the bigger portion comes from Ca2+ entry across the plasma membrane through the Orai Ca2+ channels (Feske, 2009; Kummerow et al., 2009; Hogan et al., 2010). We and others have shown that following SOCE, mitochondria neighboring the plasma membrane and the ER are able to uptake significant amounts of Ca2+ (Hoth et al., 1997, 2000; Gilabert and Parekh, 2000; Glitsch et al., 2002; Parekh, 2003; Quintana et al., 2007, 2011; Santo-Domingo and Demaurex, 2010; Quintana and Hoth, 2012). High Ca2+ levels within the mitochondrial matrix drive mitochondrial dehydrogenases and result in increased electron supply for the electron transfer chain (ETC), which in turn, results in increased ATP production (Santo-Domingo and Demaurex, 2010). However, the increased electron supply of the ETC simultaneously increases the probability for some of these electrons to leak into the inner mitochondrial membrane and reduce molecular oxygen into O2·- (Bogeski et al., 2006, 2011; Murphy, 2009). It has been proposed that at least eight possible locations exist within the ETC where this phenomenon can occur (Sena and Chandel, 2012). In most cases, electrons will leak into the mitochondrial matrix, but it is very likely that some electrons will also end up into the mitochondrial intermembrane space. O2·- can be converted by mitochondrial SODs to H2O2. Mitochondrial ROS generation appears to be temporally delayed compared to NOX-mediated ROS production and peaks 1–2 h after activation (Kaminski et al., 2012). In the last few years, several studies redefined the role of mitochondria and mitochondrial redox signals in T-cell physiology. According to these works, mitochondrial ROS are not only needed for cell death but, similar to Ca2+, are also required for proper T-cell activation and expansion. In this context, Sena et al. showed that ETC complex III-originating ROS, produced upon T-cell activation, are essential for NFAT activation as well as IL-2 production (Murphy and Siegel, 2013; Sena et al., 2013). The findings of Sena et al. are in line with a study by Kaminski and colleagues who, a few years earlier, reported that complex-I-oxidants control IL-2 and IL-4 production and activation of NF-κB and AP-1 (Kaminski et al., 2010, 2013). The authors of the latter study further supported their conclusions by examining T cells isolated from atopic dermatitis patients. Blockade of mitochondrial complex-I in these cells reduced disease-associated hyper-expression of IL-4 (Kaminski et al., 2010, 2013). In addition, a number of recent studies identified novel molecular players, which all affect mitochondrial ROS production and thereby T-cell activation as well as apoptosis (Kaminski et al., 2007, 2013; Silic-Benussi et al., 2010). In summary, it now clear that mitochondria have a complex and very important role in controlling T-cell function. In this regard, mitochondrial redox and Ca2+ homeostasis and their interplay are of vital importance. It is very likely that, in the near future, additional mitochondrial molecules will be identified as essential regulators of T-cell function and of adaptive immune responses.

What are the targets of ROS?

Studies performed in the Jurkat T-cell line suggested that the addition of H2O2 induce mitogen- activated protein kinases (MAPK) activation (Griffith et al., 1998; Lee and Esselman, 2002). Nevertheless, it became also clear that H2O2 does not regulate MAPK activation directly. In fact, inhibition of the Src kinases, PLCγ, or PKCs abrogated H2O2-mediated activation of Erk, p38, and JNK (Lee and Esselman, 2002). Moreover, Griffith et al. showed that H2O2-mediated Erk activation requires Zap-70. Indeed, treatment of the Zap-70-deficient Jurkat T-cell variant with hydrogen peroxide failed to induce Erk phosphorylation (Griffith et al., 1998). Collectively, these data suggest that H2O2 activate MAPK through molecules involved in TCR signaling.

It is has been well-known for many years that protein tyrosine phosphatases (PTPs) are targeted by H2O2, which reacts with a cysteine residue located in the catalytic center and hence inhibit PTPs (Finkel, 1998). Therefore, accordingly to a previously proposed model, H2O2 may support signaling initiation in T cells by inactivating PTPs and thus, by enhancing the activation of protein tyrosine kinases (PTKs) (Reth, 2002).

T cells express at least 45 different PTPs and most of them are negative regulators of lymphocyte activation (Mustelin et al., 2005). CD45 and Shp1, among others, have been shown to be crucial in the regulation of TCR proximal signaling (Mustelin et al., 2005). CD45 may function as both positive and negative regulator of TCR signaling. In fact, previous and more recent data have demonstrated that CD45 can dephosphorylate both the activatory Y394 and the inhibitory Y505 of Lck (D’Oro et al., 1996; Hui and Vale, 2014). Conversely, it is clear that Shp1 is a negative regulator of T-cell activation that dephosphorylates the activatory tyrosines of Lck and Zap-70 (Unkeless and Jin, 1997). Shp1-deficiency results in T-cell hyperactivation and autoimmunity (Tsui et al., 1993; Pani et al., 1996).

Both CD45 and Shp1 have been reported to be inactivated by H2O2 (Secrist et al., 1993; Cunnick et al., 1998) and more recently, it has also been shown that Shp1 and the related PTP Shp2 are sulfenylated upon antigen stimulation in murine CD8+ T cells (Michalek et al., 2007). In agreement with these data, a study from the group of M.S. Williams has also shown that Shp2 is oxidized upon CD3-mediated stimulation in Jurkat and human T-cell blasts (Kwon et al., 2005). It has been proposed that Shp2 oxidation is required to enhance Vav1 and ADAP phosphorylation, thus promoting integrin activation and T-cell adhesion. Nevertheless, Shp1 was found not to be oxidized in this study. The reason for this discrepancy is not clear. It is possible that both Shp1 and Shp2 are oxidized upon stimulation of primary resting T cells as suggested by Michalek et al., whereas Shp2, but not Shp1, is selectively oxidized in activated T cells as suggested by Kwon et al. Therefore, PTPs may show different sensitivity to oxidation depending on the activation status of the cells. These data also suggest that Shp1 and Shp2 may be located in different cell compartments with a different redox state in naïve vs. activated T cells.

Similar observations for B cells show that Shp1 and Shp2 are sulfenylated. Stimulation of the BCR results in O2·- and H2O2 production and also in Shp1/Shp2 sulfenylation in primary B cells (Capasso et al., 2010; Crump et al., 2012). Reduction in ROS production affected Shp1 sulfenylation (inactivation) and impaired B-cell signaling, activation and function (Capasso et al., 2010). These results further support the model proposed by M. Reth suggesting that H2O2 takes part in the amplification of BCR signaling (Reth, 2002; Rolli et al., 2002). Thus, sulfenylation/inactivation of PTPs like Shp1 and Shp2 appears to be a general mechanism for signal initiation and amplification downstream of the antigen receptor in both T and B lymphocytes (Figure 2).

Mechansims of action of ROS in TCR signaling. T-cell receptor (TCR) engagement induces a signaling cascade which leads to ROS production (red stars) from NADPH oxidase 2 (NOX2) at the plasma membrane, dual NADPH oxidase 1 (DUOX1) at the ER membrane, and the mitochondria. Possible targets of ROS including LAT, ZAP70, SHP-1, Lck, cofillin, CD45, and Orai1 Ca2+ channels are depicted (marked with a red star).
Figure 2:

Mechansims of action of ROS in TCR signaling.

T-cell receptor (TCR) engagement induces a signaling cascade which leads to ROS production (red stars) from NADPH oxidase 2 (NOX2) at the plasma membrane, dual NADPH oxidase 1 (DUOX1) at the ER membrane, and the mitochondria. Possible targets of ROS including LAT, ZAP70, SHP-1, Lck, cofillin, CD45, and Orai1 Ca2+ channels are depicted (marked with a red star).

Does H2O2 regulate signaling only by inactivating PTPs? A growing body of evidence suggests that H2O2 may directly influence the activity of PTKs, in particular by oxidizing cysteine residues that are not located in the catalytic site (Lee et al., 2011; Yoo et al., 2011; Paulsen et al., 2012). For example, the regulation of the activity of Src, the prototype of Src-family kinases, via oxidation-mediated cysteine modification has become the focus of intense research (Chiarugi, 2008; Giannoni et al., 2010; Corcoran and Cotter, 2013; Giannoni and Chiarugi, 2014). More recently, it has been shown that Lyn, another member of the Src-family kinases that is expressed in different immune cells, functions as a redox sensor that regulates the recruitment of neutrophils to wounds (Yoo et al., 2011). Collectively, these data suggest that, in addition to tyrosine-based regulation, Src-family kinases have another regulatory mechanism based on oxidation of cysteine residues.

T cells express two members of the Src-family, namely Lck and Fyn. Little is known about the redox regulation of Src-family kinases expressed in T cells. It appears that Fyn autophosphorylation is enhanced upon GSH treatment in a cell-free system (Hehner et al., 2000). Also Lck seems to be sensitive to oxidation both in vitro (Kanner et al., 1992; Nakamura et al., 1993; Trevillyan et al., 1999) and in vivo during HIV infection (Stefanova et al., 1996). Two decades ago it was shown that, similarly to the corresponding cysteine residues of Src, C378, C465, and C476 of Lck are crucial for its enzymatic activity, as C to A mutants of these residues displayed impaired autophosphorylation and in vitro kinase activity (Veillette et al., 1993). However, the functional significance of Lck and Fyn oxidation has yet to be elucidated (Figure 2).

Little is known also about the redox-mediated regulation of Zap-70, the other tyrosine kinase crucial for the initiation of TCR signaling. About two decades ago, it was shown that, similarly to Lck and Fyn, Zap-70 structure is altered in T cells from HIV patients (Stefanova et al., 1996). This appears to be an oxidation-mediated event as reducing agents were able to restore protein structure. Another study has shown that treatment with peroxide impaired CD3-mediated phosphorylation of Zap-70 (Chakravarti and Abraham, 2002). A more recent study has identified C39, which is located in the phosphotyrosine-binding pocket of the N-terminal SH2 domain of Zap-70, as a possible target of oxidation (Visperas et al., 2015). The proposed model postulates that H2O2 oxidizes this cysteine, thus preventing the recruitment of the Zap-70 SH2 domain to the phosphorylated ITAMs and ultimately attenuating TCR signaling (Figure 2).

A variety of other signaling molecules have been shown to possess cysteine residues that are sensitive to oxidation. Among these is the transmembrane adaptor protein LAT, which, as mentioned above, is a crucial organizer of TCR signaling. Initial evidence that LAT is sensitive to oxidation came from studies investigating altered responses in synovial fluid T cells isolated from patients suffering from rheumatoid arthritis (RA) (Gringhuis et al., 2000). T cells from RA patients are hyporesponsive to TCR stimulation and display a defective TCR-mediated LAT phosphorylation. This defect appears to be due to the displacement of LAT from the plasma membrane, where LAT coordinates TCR signaling (Figures 1 and 2). It has additionally been shown that RA T cells display reduced intracellular GSH levels, which consequently indicates higher oxidation (oxidative stress) in these cells. A key finding of this study was that treatment of T cells with N-acetyl-L-cysteine (NAC), which elevates the intracellular GSH levels, restores the membrane localization and phosphorylation of LAT and ultimately T-cell activation. An additional study from the same group has shown that three cysteines, C26 and C29, which are present at the end of the transmembrane α-helix region or just proximal of the α-helix, respectively, and C117 located approximately in the middle of the cytoplasmic domain, are sensitive to oxidation (Gringhuis et al., 2002). Indeed, mutations at cysteine residues C117 and C26/C29 confer redox insensitivity to LAT, which remains localized in the plasma membrane upon GSH depletion in Jurkat T cells. The proposed model suggests that, under oxidative conditions, C117 forms a disulfide bond with either C26 or C29, thus affecting the conformation of LAT and hence interfering with the integration of the α-helical structure of LAT into the plasma membrane.

Another study has shown that ROS participate in the formation of lipid rafts (Lu et al., 2007). Reduction of ROS levels by Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP) and NAC affects the TCR-mediated formation of lipid platform containing signaling molecules such as LAT, PLCγ1, and PKCθ, whereas the ROS-inducer TBHP (tert-butyl hydroperoxide) enhances raft formation. However, the mechanism of how ROS induce the formation of signaling platform is still unknown.

Recently, it has been shown that H2O2 have complex effects on T-cell Ca2+ homeostasis and consequently on cytokine production and viability (Bogeski et al., 2010). In a concentration-dependent manner, H2O2 caused inhibition of Orai1 and Orai2 but not of Orai3 and also induced activation of non-selective cation channels, possibly from the TRP (transient receptor potential) family. The cysteine content of Orai3 is slightly different when compared with Orai1. By creating loss-of-function and gain-of-function cysteine mutants of Orai1 and 3, it has been identified that Orai1’s cysteine 195 is the major redox sensor of the channel. For more details regarding redox regulation of ion channels in different immune and non-immune cell types we recommend the following literature: Bogeski et al. (2011); Takahashi et al. (2011); Bogeski and Niemeyer (2014); O-Uchi et al. (2014a, b); Kozai et al. (2014); Nunes and Demaurex (2014); Paula-Lima et al. (2014); Sahoo et al. (2014); Stojilkovic et al. (2014); Todorovic and Jevtovic-Todorovic (2014).

In addition, components of the actin cytoskeleton have been found to be sensitive to oxidation (Fratelli et al., 2002; Klemke et al., 2008). Actin reorganization upon TCR engagement is essential for T-cell activation and also for the migration of T cells through the body (Burkhardt et al., 2008). Cofilin is one of the key orchestrators of actin remodeling that regulates both the disassembly of existing filaments and the formation of new filaments (Samstag et al., 2013). Cofilin function is controlled by the posttranslational modification of S3. Phosphorylation of this residue reduces its actin-binding capacity, whereas dephosphorylation induces actin remodeling. TCR×CD28 stimulation induces cofilin dephosphorylation via Ras and PI3K signaling. Cofilin also contains four cysteine residues that can be potentially oxidized (Samstag et al., 2013). Indeed recent data have shown that C139 is sulfonylated, whereas C39 and C80 are possibly involved in the formation of an intramolecular disulfide bridge under oxidative stress (Klemke et al., 2008; Samstag et al., 2013). Cofilin oxidation parallels with the loss of S3 phosphorylation, thus impairing its ability to remodel actin and ultimately leading to T-cell hyporesponsiveness.

What are the downstream targets of ROS?

As mentioned above, triggering of the TCR at the plasma membrane results in IL-2 production, thus further driving proliferation and expansion of T-cell clones. At the transcriptional level, IL-2 mRNA expression is induced by the activity of three transcription factors NFAT, AP-1, and NF-κB (Rao, 1994). A number of studies suggest that H2O2 play an important role in the activation of the transcription factor NF-κB (Los et al., 1995a, b; Lahdenpohja and Hurme, 1998; Hehner et al., 2000). Two mechanisms for redox regulation of NF-κB activation have been proposed, which have been reviewed elsewhere (Kabe et al., 2005; Gloire et al., 2006). First, H2O2 can regulate NF-κB activation indirectly by stimulating the activity of tyrosine kinases (such as Lck and Zap-70), which are involved in the regulation of IκB. Subsequently, phosphorylated IkB is released from p50/p65, which in turn translocates into the nucleus, thus activating gene transcription. It has additionally been shown that the lipid phosphatase SHIP-1 plays also a role in H2O2-mediated NF-κB activation, although the exact mechanism of this regulation has not yet been elucidated. Alternatively, H2O2 can directly oxidize the IKKβ kinase likely on cysteine 179, thus inactivating NF-κB. However, this mechanism does not seem to occur in T cells. In addition to H2O2 other oxidants such as hypochlorous acid, singlet oxygen and reactive nitrogen species have also been shown to regulate NF-κB activation (Gloire et al., 2006). Also in this case, whether these mechanisms are active in T cells is still unknown. Recent data have shown that T cells from mice with reduced mitochondrial O2·- display normal NF-κB activation (Sena et al., 2013). Similarly, enhanced expression of a mitochondrial SOD (MnSOD) did not affect NF-κB activation (Gill and Levine, 2013). These data suggest that NF-κB activation does not depend on mitochondrial ROS.

Members of the MAPKs, which are required for the activation of AP-1, also seem to be regulated in a redox-dependent manner. It has been shown that the ROS scavenger L-NAC and the inhibitor of NADPH oxidases DPI suppress ConA-mediated proliferation and JNK kinase activity in murine thymocytes (Pani et al., 2000). Devadas et al. showed that CD3-mediated Erk phosphorylation depends on hydrogen peroxide but not on superoxide anion in both T-cell hybridoma and T-cell blasts (Devadas et al., 2002). Furthermore, H2O2 stimulation of Jurkat T cells induces not only Erk phosphorylation (Griffith et al., 1998; Lee and Esselman, 2002) but also activates JNK, and p38 (Lee and Esselman, 2002). In contrast to these data, it has been shown that T cells from mice with reduced mitochondrial O2·- display normal CD3xCD28-mediated Erk activation (Sena et al., 2013). Similarly, enhanced expression of MnSOD did not affect the phosphorylation of Erk, whereas JNK activation was enhanced in Jurkat T cells (Gill and Levine, 2013). Interestingly, the expression of a cytosolic SOD (Cu, Zn-SOD) had no effect (Gill and Levine, 2013). Similarly to the last study, it has been shown that oxidation appears to promote JNK and p38, but not Erk activation upon CD3×CD28 stimulation in both Jurkat and primary human T cells (Hehner et al., 2000).

Finally, TCR-mediated NFAT activation appears to be dependent on mitochondrial O2·- in mouse primary T cells (Sena et al., 2013) but not on O2·- and H2O2 in both T-cell hybridoma and T-cell blasts (Devadas et al., 2002).

Collectively, these data suggest that somehow ROS play a role in the transcriptional activation of the IL-2 promoter. Whether the modulatory effects of ROS on IL-2 production are exerted directly on transcription factors or indirectly on signaling molecules upstream of transcription are yet not completely understood. Some conflicting data have also been generated in the case of ROS-mediated IL-2 transcription. It is important to keep in mind that oxidants act within the intricate cellular network and hence ROS applied extracellularly, originated from different subcellular sources, or produced at different stages during T-cell activation may be differentially involved in the transcriptional regulation of the IL-2 gene.

Why are ROS important for T cells?

The data presented above clearly highlight a crucial function for TCR-mediated ROS production in the regulation of T-cell activation. In addition to endogenously produced ROS, T cells are also exposed to H2O2 produced by activated macrophages and neutrophils at the site of inflammation. These exogenous oxidants represent important messengers that may regulate cross-talks between immune cells under both physiological and pathological conditions. Recent data support this hypothesis. In fact, NOX2-mediated ROS production by macrophages suppresses the activation of autoreactive T cells in a collagen-induced arthritis mouse model (Gelderman et al., 2007). Neutrophils also suppress human T-cell proliferation during endotoxin-induced acute systemic inflammation by releasing H2O2 (Pillay et al., 2012).

A large body of evidence suggests that alterations of the T-cell redox homeostasis, might be involved in the pathogenesis of immune-related diseases such as AIDS (Staal et al., 1992; Herzenberg et al., 1997; Gil et al., 2003), viral infections (Chrobot et al., 2000; Kesarwani et al., 2013), cancer (Kovacic and Jacintho, 2001; Valko et al., 2007), intestinal inflammation (Reyes et al., 2005), systemic lupus erythematosus (Caza et al., 2012; Perl, 2013; Doherty et al., 2014; Kato and Perl, 2014), and other autoimmune diseases (Hultqvist et al., 2009; Kesarwani et al., 2013; Padgett et al., 2013; Ortona et al., 2014).

Conclusions and future perspectives

During recent years it has become evident that TCR triggering increases the level of intracellular ROS (such as O2·- and H2O2) via NOX enzymes and mitochondria. It is also clear that alteration in the redox equilibrium is crucial for the regulation of T-cell activation, differentiation, cytokine secretion, and apoptosis. However, despite intense scrutiny, the molecular details of how ROS regulate signaling in T cells remain still largely elusive. Recent data have demonstrated that antigen stimulation increases H2O2 level and induces sulfenylation of central signaling molecules in naive CD8+ T cells (Michalek et al., 2007). Accordingly, inhibition of sulfenylation reduced TCR signaling, T-cell activation, and proliferation.

Therefore, one of the major goals for the future is the identification of the molecular targets of ROS in T cells. Recently, new tools to analyze protein thiol oxidation have become available (Poole, 2008; Lindemann and Leichert, 2012; Ckless, 2014). These methods have been shown to be useful for profiling thiol oxidation and for thiol redox proteome analyses in cell lines (Leonard et al., 2009; Seo and Carroll, 2009; Kettenhofen and Wood, 2010). By applying the available tools for the analysis of the redox proteome, it will be possible to identify new oxidation targets in T cells. This could lead to the development of new immunomodulatory compounds for the treatment of immune-related diseases such as autoimmunity and chronic inflammation.

The second major development that might bring significant advances in our understanding of how redox signals modulate immunity is the development of genetically encoded redox sensors and their use in animal models (Belousov et al., 2006; Gutscher et al., 2008; Meyer and Dick, 2010; Mishina et al., 2012; Albrecht et al., 2014; Breckwoldt et al., 2014; Ermakova et al., 2014; Sies, 2014; Peralta et al., 2015). With such tools in hand, we could finally observe and record the spatial and temporal parameters of T-cell redox homeostasis in vivo under physiological and pathological conditions.

Acknowledgments

This work was supported by the German Research Foundation (DFG) grants SI861/3-1, SFB854 (project B19), BO3643/3-1, SFB1027 (project C4) and the HOMFOR excellent research grant by the Medical School, University of Saarland.

References

  • Acuto, O., Di Bartolo, V., and Michel, F. (2008). Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat. Rev. Immunol. 8, 699–712.CrossrefGoogle Scholar

  • Akhand, A.A., Du, J., Liu, W., Hossain, K., Miyata, T., Nagase, F., Kato, M., Suzuki, H., and Nakashima, I. (2002). Redox-linked cell surface-oriented signaling for T-cell death. Antioxid. Redox Sign. 4, 445–454.CrossrefGoogle Scholar

  • Albrecht, S.C., Sobotta, M.C., Bausewein, D., Aller, I., Hell, R., Dick, T.P., and Meyer, A.J. (2014). Redesign of genetically encoded biosensors for monitoring mitochondrial redox status in a broad range of model eukaryotes. J. Biomol. Screen. 19, 379–386.CrossrefGoogle Scholar

  • Arndt, B., Poltorak, M., Kowtharapu, B.S., Reichardt, P., Philipsen, L., Lindquist, J.A., Schraven, B., and Simeoni, L. (2013). Analysis of TCR activation kinetics in primary human T cells upon focal or soluble stimulation. J. Immunol. Methods 387, 276–283.Google Scholar

  • Bedard, K. and Krause, K.H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245–313.CrossrefGoogle Scholar

  • Belikov, A.V., Schraven, B., and Simeoni, L. (2014). TCR-triggered extracellular superoxide production is not required for T-cell activation. Cell Commun. Sign. 12, 50.CrossrefGoogle Scholar

  • Belousov, V.V., Fradkov, A.F., Lukyanov, K.A., Staroverov, D.B., Shakhbazov, K.S., Terskikh, A.V., and Lukyanov, S. (2006). Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat. Methods 3, 281–286.CrossrefGoogle Scholar

  • Bogeski, I. and Niemeyer, B.A. (2014). Redox regulation of ion channels. Antioxid. Redox Sign. 21, 859–862.CrossrefGoogle Scholar

  • Bogeski, I., Bozem, M., Sternfeld, L., Hofer, H.W., and Schulz, I. (2006). Inhibition of protein tyrosine phosphatase 1B by reactive oxygen species leads to maintenance of Ca2+ influx following store depletion in HEK 293 cells. Cell Calcium 40, 1–10.CrossrefGoogle Scholar

  • Bogeski, I., Kappl, R., Kummerow, C., Gulaboski, R., Hoth, M., and Niemeyer, B.A. (2011). Redox regulation of calcium ion channels: chemical and physiological aspects. Cell Calcium 50, 407–423.CrossrefGoogle Scholar

  • Bogeski, I., Kummerow, C., Al-Ansary, D., Schwarz, E.C., Koehler, R., Kozai, D., Takahashi, N., Peinelt, C., Griesemer, D., Bozem, M., et al. (2010). Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci. Sign. 3, ra24.Google Scholar

  • Breckwoldt, M.O., Pfister, F.M., Bradley, P.M., Marinkovic, P., Williams, P.R., Brill, M.S., Plomer, B., Schmalz, A., St Clair, D.K., Naumann, R., et al. (2014). Multiparametric optical analysis of mitochondrial redox signals during neuronal physiology and pathology in vivo. Nat. Med. 20, 555–560.CrossrefGoogle Scholar

  • Burkhardt, J.K., Carrizosa, E., and Shaffer, M.H. (2008). The actin cytoskeleton in T cell activation. Ann. Rev. Immunol. 26, 233–259.CrossrefGoogle Scholar

  • Capasso, M., Bhamrah, M.K., Henley, T., Boyd, R.S., Langlais, C., Cain, K., Dinsdale, D., Pulford, K., Khan, M., Musset, B., et al. (2010). HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat. Immunol. 11, 265–272.CrossrefGoogle Scholar

  • Caza, T.N., Talaber, G., and Perl, A. (2012). Metabolic regulation of organelle homeostasis in lupus T cells. Clin. Immunol. 144, 200–213.CrossrefGoogle Scholar

  • Chakraborty, A.K. and Weiss, A. (2014). Insights into the initiation of TCR signaling. Nat. Immunol. 15, 798–807.CrossrefGoogle Scholar

  • Chakravarti, B. and Abraham, G.N. (2002). Effect of age and oxidative stress on tyrosine phosphorylation of ZAP-70. Mech. Ageing Dev. 123, 297–311.CrossrefGoogle Scholar

  • Chaudhri, G., Clark, I.A., Hunt, N.H., Cowden, W.B., and Ceredig, R. (1986). Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J. Immunol. 137, 2646–2652.Google Scholar

  • Chaudhri, G., Hunt, N.H., Clark, I.A., and Ceredig, R. (1988). Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell. Immunol. 115, 204–213.CrossrefGoogle Scholar

  • Chiarugi, P. (2008). Src redox regulation: there is more than meets the eye. Mol. Cells 26, 329–337.Google Scholar

  • Chrobot, A.M., Szaflarska-Szczepanik, A., and Drewa, G. (2000). Antioxidant defense in children with chronic viral hepatitis B and C. Med. Sci. Monit. 6, 713–718.Google Scholar

  • Ckless, K. (2014). Redox proteomics: from bench to bedside. Adv. Exp. Med. Biol. 806, 301–317.Google Scholar

  • Corcoran, A. and Cotter, T.G. (2013). Redox regulation of protein kinases. FEBS J. 280, 1944–1965.Google Scholar

  • Crump, K.E., Juneau, D.G., Poole, L.B., Haas, K.M., and Grayson, J.M. (2012). The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur. J. Immunol. 42, 2152–2164.CrossrefGoogle Scholar

  • Cunnick, J.M., Dorsey, J.F., Mei, L., and Wu, J. (1998). Reversible regulation of SHP-1 tyrosine phosphatase activity by oxidation. Biochem. Mol. Biol. Int. 45, 887–894.Google Scholar

  • Das, J., Ho, M., Zikherman, J., Govern, C., Yang, M., Weiss, A., Chakraborty, A.K., and Roose, J.P. (2009). Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell 136, 337–351.Google Scholar

  • Devadas, S., Zaritskaya, L., Rhee, S.G., Oberley, L., and Williams, M.S. (2002). Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195, 59–70.Google Scholar

  • Doherty, E., Oaks, Z., and Perl, A. (2014). Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. Antioxid. Redox Sign. 21, 56–65.CrossrefGoogle Scholar

  • Dornand, J. and Gerber, M. (1989). Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors. Immunology 68, 384–391.Google Scholar

  • D’Oro, U., Sakaguchi, K., Appella, E., and Ashwell, J.D. (1996). Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 16, 4996–5003.Google Scholar

  • Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47–95.CrossrefGoogle Scholar

  • Ermakova, Y.G., Bilan, D.S., Matlashov, M.E., Mishina, N.M., Markvicheva, K.N., Subach, O.M., Subach, F.V., Bogeski, I., Hoth, M., Enikolopov, G., et al. (2014). Red fluorescent genetically encoded indicator for intracellular hydrogen peroxide. Nat. Commun. 5, 5222.CrossrefGoogle Scholar

  • Feske, S. (2009). ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. Immunol. Rev. 231, 189–209.CrossrefGoogle Scholar

  • Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., Tanasa, B., Hogan, P.G., Lewis, R.S., Daly, M., and Rao, A. (2006). A mutation in orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179–185.Google Scholar

  • Fidelus, R.K. (1988). The generation of oxygen radicals: a positive signal for lymphocyte activation. Cell. Immunol. 113, 175–182.CrossrefGoogle Scholar

  • Fidelus, R.K. and Tsan, M.F. (1986). Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell. Immunol. 97, 155–163.CrossrefGoogle Scholar

  • Fidelus, R.K. and Tsan, M.F. (1987). Glutathione and lymphocyte activation: a function of ageing and auto-immune disease. Immunology 61, 503–508.Google Scholar

  • Fidelus, R.K., Ginouves, P., Lawrence, D., and Tsan, M.F. (1987). Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp. Cell Res. 170, 269–275.Google Scholar

  • Finkel, T. (1998). Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10, 248–253.CrossrefGoogle Scholar

  • Fratelli, M., Demol, H., Puype, M., Casagrande, S., Eberini, I., Salmona, M., Bonetto, V., Mengozzi, M., Duffieux, F., Miclet, E., et al. (2002). Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA 99, 3505–3510.CrossrefGoogle Scholar

  • Gelderman, K.A., Hultqvist, M., Pizzolla, A., Zhao, M., Nandakumar, K.S., Mattsson, R., and Holmdahl, R. (2007). Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117, 3020–3028.CrossrefGoogle Scholar

  • Gerber, M., Ball, D., Michel, F., and Crastes de Paulet, A. (1985). Mechanism of enhancing effect of irradiation on production of IL-2. Immunol. Lett. 9, 279–283.CrossrefGoogle Scholar

  • Giannoni, E. and Chiarugi, P. (2014). Redox circuitries driving src regulation. Antioxid. Redox Sign. 20, 2011–2025.CrossrefGoogle Scholar

  • Giannoni, E., Taddei, M.L., and Chiarugi, P. (2010). Src redox regulation: again in the front line. Free Rad. Biol. Med. 49, 516–527.Google Scholar

  • Gil, L., Martinez, G., Gonzalez, I., Tarinas, A., Alvarez, A., Giuliani, A., Molina, R., Tapanes, R., Perez, J., and Leon, O.S. (2003). Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol. Res. 47, 217–224.CrossrefGoogle Scholar

  • Gilabert, J.A. and Parekh, A.B. (2000). Respiring mitochondria determine the pattern of activation and inactivation of the store-operated Ca2+ current I (CRAC). EMBO J. 19, 6401–6407.CrossrefGoogle Scholar

  • Gill, T. and Levine, A.D. (2013). Mitochondria-derived hydrogen peroxide selectively enhances T cell receptor-initiated signal transduction. J. Biol. Chem. 288, 26246–26255.Google Scholar

  • Glitsch, M.D., Bakowski, D., and Parekh, A.B. (2002). Store-operated Ca2+ entry depends on mitochondrial Ca2+ uptake. EMBO J. 21, 6744–6754.CrossrefGoogle Scholar

  • Gloire, G., Legrand-Poels, S., and Piette, J. (2006). NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493–1505.CrossrefGoogle Scholar

  • Gmunder, H., Roth, S., Eck, H.P., Gallas, H., Mihm, S., and Droge, W. (1990). Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. Cell. Immunol. 130, 520–528.Google Scholar

  • Goldsmith, M.A. and Weiss, A. (1987). Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. USA 84, 6879–6883.CrossrefGoogle Scholar

  • Griffith, C.E., Zhang, W., and Wange, R.L. (1998). ZAP-70-dependent and -independent activation of Erk in Jurkat T cells. Differences in signaling induced by H2O2 and CD3 cross-linking. J. Biol. Chem. 273, 10771–10776.Google Scholar

  • Gringhuis, S.I., Leow, A., Papendrecht-Van Der Voort, E.A., Remans, P.H., Breedveld, F.C., and Verweij, C.L. (2000). Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J. Immunol. 164, 2170–2179.CrossrefGoogle Scholar

  • Gringhuis, S.I., Papendrecht-van der Voort, E.A., Leow, A., Nivine Levarht, E.W., Breedveld, F.C., and Verweij, C.L. (2002). Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol. Cell. Biol. 22, 400–411.CrossrefGoogle Scholar

  • Gutscher, M., Pauleau, A.L., Marty, L., Brach, T., Wabnitz, G.H., Samstag, Y., Meyer, A.J., and Dick, T.P. (2008). Real-time imaging of the intracellular glutathione redox potential. Nat. Methods 5, 553–559.CrossrefGoogle Scholar

  • Hehner, S.P., Breitkreutz, R., Shubinsky, G., Unsoeld, H., Schulze-Osthoff, K., Schmitz, M.L., and Droge, W. (2000). Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol. 165, 4319–4328.CrossrefGoogle Scholar

  • Herzenberg, L.A., De Rosa, S.C., Dubs, J.G., Roederer, M., Anderson, M.T., Ela, S.W., Deresinski, S.C., and Herzenberg, L.A. (1997). Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA 94, 1967–1972.CrossrefGoogle Scholar

  • Hildeman, D.A., Mitchell, T., Kappler, J., and Marrack, P. (2003). T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111, 575–581.CrossrefGoogle Scholar

  • Hildeman, D.A., Mitchell, T., Teague, T.K., Henson, P., Day, B.J., Kappler, J., and Marrack, P.C. (1999). Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735–744.CrossrefGoogle Scholar

  • Hogan, P.G., Lewis, R.S., and Rao, A. (2010). Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Ann. Rev. Immunol. 28, 491–533.CrossrefGoogle Scholar

  • Hoth, M. and Penner, R. (1992). Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355, 353–356.CrossrefGoogle Scholar

  • Hoth, M., Fanger, C.M., and Lewis, R.S. (1997). Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J. Cell Biol. 137, 633–648.CrossrefGoogle Scholar

  • Hoth, M., Button, D.C., and Lewis, R.S. (2000). Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes. Proc. Natl. Acad. Sci. USA 97, 10607–10612.CrossrefGoogle Scholar

  • Hui, E. and Vale, R.D. (2014). In vitro membrane reconstitution of the T-cell receptor proximal signaling network. Nat. Struct. Mol. Biol. 21, 133–142.CrossrefGoogle Scholar

  • Hultqvist, M., Olsson, L.M., Gelderman, K.A., and Holmdahl, R. (2009). The protective role of ROS in autoimmune disease. Trends Immunol. 30, 201–208.CrossrefGoogle Scholar

  • Jackson, S.H., Devadas, S., Kwon, J., Pinto, L.A., and Williams, M.S. (2004). T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5, 818–827.CrossrefGoogle Scholar

  • Jones, R.G., Bui, T., White, C., Madesh, M., Krawczyk, C.M., Lindsten, T., Hawkins, B.J., Kubek, S., Frauwirth, K.A., Wang, Y.L., et al. (2007). The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca2+ homeostasis. Immunity 27, 268–280.CrossrefGoogle Scholar

  • Kabe, Y., Ando, K., Hirao, S., Yoshida, M., and Handa, H. (2005). Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Sign. 7, 395–403.CrossrefGoogle Scholar

  • Kaminski, M., Kiessling, M., Suss, D., Krammer, P.H., and Gulow, K. (2007). Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol. Cell. Biol. 27, 3625–3639.CrossrefGoogle Scholar

  • Kaminski, M.M., Sauer, S.W., Klemke, C.D., Suss, D., Okun, J.G., Krammer, P.H., and Gulow, K. (2010). Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression. J. Immunol. 184, 4827–4841.Google Scholar

  • Kaminski, M.M., Roth, D., Sass, S., Sauer, S.W., Krammer, P.H., and Gulow, K. (2012). Manganese superoxide dismutase: a regulator of T cell activation-induced oxidative signaling and cell death. Biochim. Biophys. Acta 1823, 1041–1052.Google Scholar

  • Kaminski, M.M., Roth, D., Krammer, P.H., and Gulow, K. (2013). Mitochondria as oxidative signaling organelles in T-cell activation: physiological role and pathological implications. Arch. Immunol. Ther. Exp. (Warsz.) 61, 367–384.CrossrefGoogle Scholar

  • Kanner, S.B., Kavanagh, T.J., Grossmann, A., Hu, S.L., Bolen, J.B., Rabinovitch, P.S., and Ledbetter, J.A. (1992). Sulfhydryl oxidation down-regulates T-cell signaling and inhibits tyrosine phosphorylation of phospholipase Cγ 1. Proc. Natl. Acad. Sci. USA 89, 300–304.CrossrefGoogle Scholar

  • Kato, H. and Perl, A. (2014). Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J. Immunol. 192, 4134–4144.Google Scholar

  • Kesarwani, P., Murali, A.K., Al-Khami, A.A., and Mehrotra, S. (2013). Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid. Redox Sign. 18, 1497–1534.CrossrefGoogle Scholar

  • Kettenhofen, N.J. and Wood, M.J. (2010). Formation, reactivity, and detection of protein sulfenic acids. Chem. Res. Toxicol. 23, 1633–1646.CrossrefGoogle Scholar

  • Klemke, M., Wabnitz, G.H., Funke, F., Funk, B., Kirchgessner, H., and Samstag, Y. (2008). Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 29, 404–413.CrossrefGoogle Scholar

  • Kovacic, P. and Jacintho, J.D. (2001). Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem. 8, 773–796.CrossrefGoogle Scholar

  • Kozai, D., Ogawa, N., and Mori, Y. (2014). Redox regulation of transient receptor potential channels. Antioxid. Redox Sign. 21, 971–986.CrossrefGoogle Scholar

  • Kummerow, C., Junker, C., Kruse, K., Rieger, H., Quintana, A., and Hoth, M. (2009). The immunological synapse controls local and global calcium signals in T lymphocytes. Immunol. Rev. 231, 132–147.Google Scholar

  • Kwon, J., Devadas, S., and Williams, M.S. (2003). T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation. Free Rad. Biol. Med. 35, 406–417.Google Scholar

  • Kwon, J., Qu, C.K., Maeng, J.S., Falahati, R., Lee, C., and Williams, M.S. (2005). Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J. 24, 2331–2341.CrossrefGoogle Scholar

  • Kwon, J., Shatynski, K.E., Chen, H., Morand, S., de Deken, X., Miot, F., Leto, T.L., and Williams, M.S. (2010). The non-phagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling. Sci. Sign. 3, ra59.Google Scholar

  • Lahdenpohja, N. and Hurme, M. (1998). CD28-mediated activation in CD45RA+ and CD45RO+ T cells: enhanced levels of reactive oxygen intermediates and c-Rel nuclear translocation in CD45RA+ cells. J. Leukoc. Biol. 63, 775–780.Google Scholar

  • Lee, K. and Esselman, W.J. (2002). Inhibition of PTPs by H2O2 regulates the activation of distinct MAPK pathways. Free Rad. Biol. Med. 33, 1121–1132.Google Scholar

  • Lee, M., Choy, W.C., and Abid, M.R. (2011). Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src. PLoS One 6, e28454.Google Scholar

  • Leonard, S.E., Reddie, K.G., and Carroll, K.S. (2009). Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem. Biol. 4, 783–799.CrossrefGoogle Scholar

  • Lin, X. and Wang, D. (2004). The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin. Immunol. 16, 429–435.Google Scholar

  • Lindemann, C. and Leichert, L.I. (2012). Quantitative redox proteomics: the NOxICAT method. Methods Mol. Biol. 893, 387–403.Google Scholar

  • Liou, J., Kim, M.L., Heo, W.D., Jones, J.T., Myers, J.W., Ferrell, J.E., Jr., and Meyer, T. (2005). STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 15, 1235–1241.Google Scholar

  • Lis, A., Peinelt, C., Beck, A., Parvez, S., Monteilh-Zoller, M., Fleig, A., and Penner, R. (2007). CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr. Biol. 17, 794–800.CrossrefGoogle Scholar

  • Los, M., Droge, W., Stricker, K., Baeuerle, P.A., and Schulze-Osthoff, K. (1995a). Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25, 159–165.CrossrefGoogle Scholar

  • Los, M., Schenk, H., Hexel, K., Baeuerle, P.A., Droge, W., and Schulze-Osthoff, K. (1995b). IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14, 3731–3740.Google Scholar

  • Lu, S.P., Lin Feng, M.H., Huang, H.L., Huang, Y.C., Tsou, W.I., and Lai, M.Z. (2007). Reactive oxygen species promote raft formation in T lymphocytes. Free Rad. Biol. Med. 42, 936–944.Google Scholar

  • Meyer, A.J. and Dick, T.P. (2010). Fluorescent protein-based redox probes. Antioxid. Redox Sign. 13, 621–650.CrossrefGoogle Scholar

  • Michalek, R.D., Nelson, K.J., Holbrook, B.C., Yi, J.S., Stridiron, D., Daniel, L.W., Fetrow, J.S., King, S.B., Poole, L.B., and Grayson, J.M. (2007). The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J. Immunol. 179, 6456–6467.Google Scholar

  • Mishina, N.M., Bogeski, I., Bolotin, D.A., Hoth, M., Niemeyer, B.A., Schultz, C., Zagaynova, E.V., Lukyanov, S., and Belousov, V.V. (2012). Can we see PIP3 and hydrogen peroxide with a single probe? Antioxid. Redox Sign. 17, 505–512.CrossrefGoogle Scholar

  • Molina, T.J., Kishihara, K., Siderovski, D.P., van Ewijk, W., Narendran, A., Timms, E., Wakeham, A., Paige, C.J., Hartmann, K.U., Veillette, A., et al. (1992). Profound block in thymocyte development in mice lacking p56lck. Nature 357, 161–164.Google Scholar

  • Murphy, M.P. (2009). How mitochondria produce reactive oxygen species. Biochem. J. 417, 1–13.Google Scholar

  • Murphy, M.P. and Siegel, R.M. (2013). Mitochondrial ROS fire up T cell activation. Immunity 38, 201–202.CrossrefGoogle Scholar

  • Mustelin, T., Vang, T., and Bottini, N. (2005). Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 5, 43–57.CrossrefGoogle Scholar

  • Nakamura, K., Hori, T., Sato, N., Sugie, K., Kawakami, T., and Yodoi, J. (1993). Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8, 3133–3139.Google Scholar

  • Negishi, I., Motoyama, N., Nakayama, K., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q., Chan, A.C., and Loh, D.Y. (1995). Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376, 435–438.Google Scholar

  • Novogrodsky, A., Ravid, A., Rubin, A.L., and Stenzel, K.H. (1982). Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc. Natl. Acad. Sci. USA 79, 1171–1174.CrossrefGoogle Scholar

  • Nunes, P. and Demaurex, N. (2014). Redox regulation of store-operated Ca2+ entry. Antioxid. Redox Sign. 21, 915–932.CrossrefGoogle Scholar

  • Ortona, E., Maselli, A., Delunardo, F., Colasanti, T., Giovannetti, A., and Pierdominici, M. (2014). Relationship between redox status and cell fate in immunity and autoimmunity. Antioxid. Redox Sign. 21, 103–122.CrossrefGoogle Scholar

  • O-Uchi, J., Jhun, B.S., Xu, S., Hurst, S., Raffaello, A., Liu, X., Yi, B., Zhang, H., Gross, P., Mishra, J., et al. (2014a). Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter. Antioxid. Redox Sign. 21, 863–879.Google Scholar

  • O-Uchi, J., Ryu, S.Y., Jhun, B.S., Hurst, S., and Sheu, S.S. (2014b). Mitochondrial ion channels/transporters as sensors and regulators of cellular redox signaling. Antioxid. Redox Sign. 21, 987–1006.CrossrefGoogle Scholar

  • Padgett, L.E., Broniowska, K.A., Hansen, P.A., Corbett, J.A., and Tse, H.M. (2013). The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann. NY Acad. Sci. 1281, 16–35.Google Scholar

  • Pani, G., Fischer, K.D., Mlinaric-Rascan, I., and Siminovitch, K.A. (1996). Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184, 839–852.Google Scholar

  • Pani, G., Colavitti, R., Borrello, S., and Galeotti, T. (2000). Endogenous oxygen radicals modulate protein tyrosine phosphorylation and JNK-1 activation in lectin-stimulated thymocytes. Biochem. J. 347, 173–181.Google Scholar

  • Parekh, A.B. (2003). Store-operated Ca2+ entry: dynamic interplay between endoplasmic reticulum, mitochondria and plasma membrane. J. Physiol. 547, 333–348.Google Scholar

  • Parekh, A.B. and Putney, J.W., Jr. (2005). Store-operated calcium channels. Physiol. Rev. 85, 757–810.CrossrefGoogle Scholar

  • Patterson, D.A., Rapoport, R., Patterson, M.A., Freed, B.M., and Lempert, N. (1988). Hydrogen peroxide-mediated inhibition of T-cell response to mitogens is a result of direct action on T cells. Arch. Surg. 123, 300–304.CrossrefGoogle Scholar

  • Paula-Lima, A.C., Adasme, T., and Hidalgo, C. (2014). Contribution of Ca2+ release channels to hippocampal synaptic plasticity and spatial memory: potential redox modulation. Antioxid. Redox Sign. 21, 892–914.CrossrefGoogle Scholar

  • Paulsen, C.E., Truong, T.H., Garcia, F.J., Homann, A., Gupta, V., Leonard, S.E., and Carroll, K.S. (2012). Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat. Chem. Biol. 8, 57–64.CrossrefGoogle Scholar

  • Peralta, D., Bronowska, A.K., Morgan, B., Doka, E., Van Laer, K., Nagy, P., Grater, F., and Dick, T.P. (2015). A proton relay enhances H2O2 sensitivity of GAPDH to facilitate metabolic adaptation. Nat. Chem. Biol. 11, 156–163.CrossrefGoogle Scholar

  • Perl, A. (2013). Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 674–686.CrossrefGoogle Scholar

  • Pillay, J., Kamp, V.M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.W., Ulfman, L.H., Leenen, L.P., Pickkers, P., and Koenderman, L. (2012). A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327–336.CrossrefGoogle Scholar

  • Poltorak, M., Meinert, I., Stone, J.C., Schraven, B., and Simeoni, L. (2014). Sos1 regulates sustained TCR-mediated Erk activation. Eur. J. Immunol. 44, 1535–1540.CrossrefGoogle Scholar

  • Poole, L.B. (2008). Measurement of protein sulfenic acid content. Current protocols in toxicology/editorial board, Mahin D Maines Chapter 17, Unit17 12.Google Scholar

  • Quintana, A. and Hoth, M. (2012). Mitochondrial dynamics and their impact on T cell function. Cell Calc. 52, 57–63.CrossrefGoogle Scholar

  • Quintana, A., Pasche, M., Junker, C., Al-Ansary, D., Rieger, H., Kummerow, C., Nunez, L., Villalobos, C., Meraner, P., Becherer, U., et al. (2011). Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J. 30, 3895–3912.CrossrefGoogle Scholar

  • Quintana, A., Schwindling, C., Wenning, A.S., Becherer, U., Rettig, J., Schwarz, E.C., and Hoth, M. (2007). T cell activation requires mitochondrial translocation to the immunological synapse. Proc. Natl. Acad. Sci. USA 104, 14418–14423.CrossrefGoogle Scholar

  • Rao, A. (1994). NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274–281.CrossrefGoogle Scholar

  • Remans, P.H., Gringhuis, S.I., van Laar, J.M., Sanders, M.E., Papendrecht-van der Voort, E.A., Zwartkruis, F.J., Levarht, E.W., Rosas, M., Coffer, P.J., Breedveld, F.C., et al. (2004). Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J. Immunol. 173, 920–931.Google Scholar

  • Reth, M. (2002). Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129–1134.CrossrefGoogle Scholar

  • Reyes, B.M., Danese, S., Sans, M., Fiocchi, C., and Levine, A.D. (2005). Redox equilibrium in mucosal T cells tunes the intestinal TCR signaling threshold. J. Immunol. 175, 2158–2166.Google Scholar

  • Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W.W., Zurn, C., and Reth, M. (2002). Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop. Mol. Cell 10, 1057–1069.CrossrefGoogle Scholar

  • Roose, J. and Weiss, A. (2000). T cells: getting a GRP on Ras. Nat. Immunol. 1, 275–276.CrossrefGoogle Scholar

  • Roose, J.P., Mollenauer, M., Ho, M., Kurosaki, T., and Weiss, A. (2007). Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol. Cell. Biol. 27, 2732–2745.CrossrefGoogle Scholar

  • Roth, S. and Droge, W. (1987). Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. Cell. Immunol. 108, 417–424.CrossrefGoogle Scholar

  • Roth, S. and Droge, W. (1991). Regulation of interleukin 2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactate. European J. Immunol. 21, 1933–1937.Google Scholar

  • Sahoo, N., Hoshi, T., and Heinemann, S.H. (2014). Oxidative modulation of voltage-gated potassium channels. Antioxid. Redox Sign. 21, 933–952.CrossrefGoogle Scholar

  • Samelson, L.E. (2011). Immunoreceptor signaling. Cold Spring Harb. Perspect. Biol. 3, pii: a011510.Google Scholar

  • Samstag, Y., John, I., and Wabnitz, G.H. (2013). Cofilin: a redox sensitive mediator of actin dynamics during T-cell activation and migration. Immunol. Rev. 256, 30–47.Google Scholar

  • Santo-Domingo, J. and Demaurex, N. (2010). Calcium uptake mechanisms of mitochondria. Biochim. Biophys. Acta 1797, 907–912.Google Scholar

  • Schindl, R., Frischauf, I., Bergsmann, J., Muik, M., Derler, I., Lackner, B., Groschner, K., and Romanin, C. (2009). Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. Proc. Natl. Acad. Sci. USA 106, 19623–19628.Google Scholar

  • Secrist, J.P., Burns, L.A., Karnitz, L., Koretzky, G.A., and Abraham, R.T. (1993). Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268, 5886–5893.Google Scholar

  • Sekkat, C., Dornand, J., and Gerber, M. (1988). Oxidative phenomena are implicated in human T-cell stimulation. Immunology 63, 431–437.Google Scholar

  • Sena, L.A. and Chandel, N.S. (2012). Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158–167.CrossrefGoogle Scholar

  • Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A., Wang, C.R., Schumacker, P.T., Licht, J.D., Perlman, H., et al. (2013). Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225–236.CrossrefGoogle Scholar

  • Seo, Y.H. and Carroll, K.S. (2009). Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc. Natl. Acad. Sci. USA 106, 16163–16168.CrossrefGoogle Scholar

  • Sies, H. (2014). Role of metabolic H2O2 generation: redox signaling and oxidative stress. J. Biol. Chem. 289, 8735–8741.Google Scholar

  • Silic-Benussi, M., Cavallari, I., Vajente, N., Vidali, S., Chieco-Bianchi, L., Di Lisa, F., Saggioro, D., D’Agostino, D.M., and Ciminale, V. (2010). Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells. Blood 116, 54–62.Google Scholar

  • Smith-Garvin, J.E., Koretzky, G.A., and Jordan, M.S. (2009). T cell activation. Ann. Rev. Immunol. 27, 591–619.CrossrefGoogle Scholar

  • Smyth, M.J. (1991). Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J. Immunol. 146, 1921–1927.Google Scholar

  • Staal, F.J., Ela, S.W., Roederer, M., Anderson, M.T., Herzenberg, L.A., and Herzenberg, L.A. (1992). Glutathione deficiency and human immunodeficiency virus infection. Lancet 339, 909–912.Google Scholar

  • Stefanova, I., Saville, M.W., Peters, C., Cleghorn, F.R., Schwartz, D., Venzon, D.J., Weinhold, K.J., Jack, N., Bartholomew, C., Blattner, W.A., et al. (1996). HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J. Clin. Invest. 98, 1290–1297.CrossrefGoogle Scholar

  • Stojilkovic, S.S., Leiva-Salcedo, E., Rokic, M.B., and Coddou, C. (2014). Regulation of ATP-gated P2X channels: from redox signaling to interactions with other proteins. Antioxid. Redox Sign. 21, 953–970.CrossrefGoogle Scholar

  • Suthanthiran, M., Anderson, M.E., Sharma, V.K., and Meister, A. (1990). Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA 87, 3343–3347.Google Scholar

  • Takahashi, N., Kozai, D., Kobayashi, R., Ebert, M., and Mori, Y. (2011). Roles of TRPM2 in oxidative stress. Cell Calcium 50, 279–287.CrossrefGoogle Scholar

  • Tatla, S., Woodhead, V., Foreman, J.C., and Chain, B.M. (1999). The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Rad. Biol. Med. 26, 14–24.Google Scholar

  • Todorovic, S.M. and Jevtovic-Todorovic, V. (2014). Redox regulation of neuronal voltage-gated calcium channels. Antioxid. Redox Sign. 21, 880–891.CrossrefGoogle Scholar

  • Trevillyan, J.M., Chiou, X.G., Ballaron, S.J., Tang, Q.M., Buko, A., Sheets, M.P., Smith, M.L., Putman, C.B., Wiedeman, P., Tu, N., et al. (1999). Inhibition of p56(lck) tyrosine kinase by isothiazolones. Arch. Biochem. Biophys. 364, 19–29.Google Scholar

  • Tripathi, P. and Hildeman, D. (2004). Sensitization of T cells to apoptosis – a role for ROS? Apoptosis 9, 515–523.CrossrefGoogle Scholar

  • Tsui, H.W., Siminovitch, K.A., de Souza, L., and Tsui, F.W. (1993). Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4, 124–129.CrossrefGoogle Scholar

  • Ueda, S., Masutani, H., Nakamura, H., Tanaka, T., Ueno, M., and Yodoi, J. (2002). Redox control of cell death. Antioxid. Redox Sign. 4, 405–414.CrossrefGoogle Scholar

  • Unkeless, J.C. and Jin, J. (1997). Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immunol. 9, 338–343.CrossrefGoogle Scholar

  • Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. J. Biochem. Cell Biol. 39, 44–84.CrossrefGoogle Scholar

  • Veillette, A., Dumont, S., and Fournel, M. (1993). Conserved cysteine residues are critical for the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck. J. Biol. Chem. 268, 17547–17553.Google Scholar

  • Visperas, P.R., Winger, J.A., Horton, T.M., Shah, N.H., Aum, D.J., Tao, A., Barros, T., Yan, Q., Wilson, C.G., Arkin, M.R., et al. (2015). Modification by covalent reaction or oxidation of cysteine residues in the tandem-SH2 Domains of ZAP-70 and Syk can block phosphopeptide binding. Biochem. J. 465, 149–161.Google Scholar

  • Wang, H., Kadlecek, T.A., Au-Yeung, B.B., Goodfellow, H.E., Hsu, L.Y., Freedman, T.S., and Weiss, A. (2010). ZAP-70: an essential kinase in T-cell signaling. Cold Spring Harb. Perspect. Biol. 2, a002279.Google Scholar

  • Wange, R.L. (2000). LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways. Sci. STKE. 2000, re1.Google Scholar

  • Warnecke, N., Poltorak, M., Kowtharapu, B.S., Arndt, B., Stone, J.C., Schraven, B., and Simeoni, L. (2012). TCR-mediated Erk activation does not depend on Sos and Grb2 in peripheral human T cells. EMBO Rep. 13, 386–391.CrossrefGoogle Scholar

  • Williams, B.L., Schreiber, K.L., Zhang, W., Wange, R.L., Samelson, L.E., Leibson, P.J., and Abraham, R.T. (1998). Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18, 1388–1399.CrossrefGoogle Scholar

  • Williams, M.S. and Kwon, J. (2004). T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Rad. Biol. Med. 37, 1144–1151.Google Scholar

  • Yoo, S.K., Starnes, T.W., Deng, Q., and Huttenlocher, A. (2011). Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480, 109–112.Google Scholar

  • Zhang, S.L., Yu, Y., Roos, J., Kozak, J.A., Deerinck, T.J., Ellisman, M.H., Stauderman, K.A., and Cahalan, M.D. (2005). STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 437, 902–905.Google Scholar

  • Zorov, D.B., Juhaszova, M., and Sollott, S.J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909–950.CrossrefGoogle Scholar

About the article

Corresponding author: Luca Simeoni, Institute of Molecular and Clinical Immunology, Otto von Guericke University, Leipziger Straße 44, D-39120 Magdeburg, Germany, e-mail:


Received: 2014-12-12

Accepted: 2015-02-27

Published Online: 2015-03-10

Published in Print: 2015-05-01


Citation Information: Biological Chemistry, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/hsz-2014-0312.

Export Citation

©2015 by De Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Dana M. Previte and Jon D. Piganelli
Antioxidants & Redox Signaling, 2017
[2]
Inken Lorenzen, Lisa Mullen, Sander Bekeschus, and Eva-Maria Hanschmann
Oxidative Medicine and Cellular Longevity, 2017, Volume 2017, Page 1
[3]
Seeyoung Choi, Richard Cornall, Renaud Lesourne, and Paul E. Love
Trends in Immunology, 2017, Volume 38, Number 9, Page 622
[4]
Xiao Zhou, Renping Zhao, Karsten Schwarz, Matthieu Mangeat, Eva C. Schwarz, Mohamed Hamed, Ivan Bogeski, Volkhard Helms, Heiko Rieger, and Bin Qu
Scientific Reports, 2017, Volume 7, Page 44357
[5]
Seeyoung Choi, Claude Warzecha, Ekaterina Zvezdova, Jan Lee, Jérémy Argenty, Renaud Lesourne, L Aravind, and Paul E Love
Nature Immunology, 2017, Volume 18, Number 4, Page 433
[6]
Sander Bekeschus, Katrin Rödder, Anke Schmidt, Matthias B. Stope, Thomas von Woedtke, Vandana Miller, Alexander Fridman, Klaus-Dieter Weltmann, Kai Masur, Hans-Robert Metelmann, Kristian Wende, and Sybille Hasse
Plasma Processes and Polymers, 2016, Volume 13, Number 12, Page 1144
[7]
Marcin M. Kamiński, Swantje Liedmann, Sandra Milasta, and Douglas R. Green
Seminars in Immunology, 2016, Volume 28, Number 5, Page 525
[8]
Toshiro Hirai, Yasuo Yoshioka, Asako Udaka, Eiichiro Uemura, Tomoyuki Ohe, Hisae Aoshima, Jian-Qing Gao, Ken Kokubo, Takumi Oshima, Kazuya Nagano, Kazuma Higashisaka, Tadahiko Mashino, and Yasuo Tsutsumi
Nanoscale Research Letters, 2016, Volume 11, Number 1
[9]
Lin Liu, Yongping Ma, Huicong Zhou, and Mingjun Wu
International Journal of Molecular Sciences, 2016, Volume 17, Number 9, Page 1419
[10]
Naazneen Moolla, Mark Killick, Maria Papathanasopoulos, and Alexio Capovilla
Biochimica et Biophysica Acta (BBA) - General Subjects, 2016, Volume 1860, Number 9, Page 1854
[11]
Moran Benhar, Iart Luca Shytaj, Jonathan S. Stamler, and Andrea Savarino
Journal of Clinical Investigation, 2016, Volume 126, Number 5, Page 1630
[12]
Christine S. Gibhardt, Katharina M. Zimmermann, Xin Zhang, Vsevolod V. Belousov, and Ivan Bogeski
Cell Calcium, 2016, Volume 60, Number 2, Page 55
[13]
Xiran Lin and Tian Huang
Free Radical Research, 2016, Volume 50, Number 6, Page 585
[14]
Judith Agudo and Brian D. Brown
Immunity, 2016, Volume 44, Number 3, Page 520
[15]
Luca Simeoni, Christoph Thurm, Andreas Kritikos, and Andreas Linkermann
Clinical Kidney Journal, 2016, Volume 9, Number 1, Page 1

Comments (0)

Please log in or register to comment.
Log in